Documents | Adefovir dipivoxil and peginterferon alfa-2a for the treatment of chronic hepatitis B | Guidance | NICE

Documents

A list of downloadable documents created during development.

Background information

Hepatitis B (chronic) - adefovir dipivoxil and pegylated interferon alfa-2a: review decison - October 2011 information
Appendix A: decision paper presented to the Institute's Guidance Executive ^{PDF 106.17 KB} 10 October 2011
Hepatitis B (chronic) - adefovir dipivoxil and pegylated interferon alfa-2a: review proposal - July 2011 information
Appendix A: provisional matrix of stakeholders ^{PDF 74.36 KB} 01 August 2011
Appendix B: proposal paper presented to the Institute's Guidance Executive ^{PDF 137.88 KB} 01 August 2011
Review decision: June 2009 information
Appendix 1: Proposal comment summary table ^{PDF 28.37 KB} 22 June 2009
Review proposal: May 2009 information
Review proposal: May 2009, Appendix A - Provisional matrix ^{PDF 36.91 KB} 06 May 2009
Review decision, October 2007 information
Department of Health ^{PDF 27.84 KB} 26 October 2007
Royal College of Nursing ^{PDF 19.79 KB} 26 October 2007
Royal College of Physicians ^{PDF 11.11 KB} 26 October 2007
NHS Quality Improvement Scotland ^{PDF 19.54 KB} 26 October 2007
Novartis Pharmaceuticals ^{PDF 11.07 KB} 26 October 2007
Royal Pharmaceutical Society ^{PDF 11.08 KB} 26 October 2007
Gilead Sciences ^{PDF 12.91 KB} 26 October 2007
Royal Pharmaceutical Society ^{PDF 11.08 KB} 26 October 2007
Royal College of Physicians ^{PDF 11.11 KB} 26 October 2007
Royal College of Nursing ^{PDF 19.79 KB} 26 October 2007
Novartis Pharmaceuticals ^{PDF 11.07 KB} 26 October 2007
NHS Quality Improvement Scotland ^{PDF 19.54 KB} 26 October 2007
Gilead Sciences ^{PDF 12.91 KB} 26 October 2007
Department of Health ^{PDF 27.84 KB} 26 October 2007
Review proposal, July 2007 information
Hepatitis B (chronic) - adefovir dipivoxil and pegylated interferon alfa-2a: assessment report ^{PDF 2.49 MB} 22 August 2005
People with chronic hepatitis B to benefit from guidance on new drugs and treatments information
People with chronic hepatitis B to benefit from guidance on new drugs and treatments ^{PDF 47.11 KB} 22 February 2006
Appendix A
Appendix A - matrix of consultees and commentators ^{PDF 50.51 KB} 30 July 2007
Appendix 1: Proposal comment summary table ^{PDF 28.37 KB} 22 June 2009

Final Appraisal Determination: Hepatitis B (chronic) - adefovir dipivoxil and pegylated interferon alpha-2a

Appraisal Consultation Document: Hepatitis B (chronic) - adefovir dipivoxil and pegylated interferon alpha-2a

Appraisal Consultation Document: Hepatitis B (chronic) - adefovir dipivoxil and pegylated interferon alpha-2a information

Evaluation report

Evaluation report
Overview ^{PDF 190.18 KB} 22 August 2005
Consultee and commentator comments on the assessment report
British Association for Sexual Health and HIV (BASHH) ^{PDF 18.04 KB} 22 August 2005
Gilead Sciences ^{PDF 220.99 KB} 22 August 2005
MRC Clinical Trials Unit ^{PDF 32.86 KB} 22 August 2005
Roche Products Limited ^{PDF 36.47 KB} 22 August 2005
Roche Products Limited (cont) ^{PDF 172.59 KB} 22 August 2005
Roche Products Limited (cont) ^{PDF 268.82 KB} 22 August 2005
Royal College of Nursing ^{PDF 16.18 KB} 22 August 2005
Royal College of Pathologists ^{PDF 10.81 KB} 22 August 2005
Royal College of Physicians ^{PDF 45.16 KB} 22 August 2005
Non-manufacturer submissions
Royal College of Nursing ^{PDF 30.3 KB} 22 August 2005
Royal College of Physicians, The British Association for the study of the Liver, and the British Society of Gastroenterology (joint submission) ^{PDF 140.42 KB} 22 August 2005
Manufacturer submissions (executive summary only)
Gilead Sciences ^{PDF 77.58 KB} 22 August 2005
Roche Products Ltd ^{PDF 44.9 KB} 22 August 2005
Expert written personal statements
Dusheiko ^{PDF 53.83 KB} 22 August 2005
Thomas ^{PDF 30.4 KB} 22 August 2005

Final scope

Final scope ^{PDF 30.33 KB} 29 October 2004

Summary of consultee and commentator comments of the draft scope

Summary of consultee and commentator comments of the draft scope ^{PDF 38.43 KB} 29 October 2004

Summary of consultee and commentator comments on the draft matrix

Summary of consultee and commentator comments on the draft matrix ^{PDF 15.08 KB} 29 October 2004

Archive: Draft scope

Archive: Draft scope ^{PDF 83.83 KB} 07 October 2004

Archive: Provisional matrix

Archive: Provisional matrix ^{PDF 27.5 KB} 07 October 2004